Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs Novartis AG (NVS) Price & Performance

AstraZeneca plcTrade
Novartis AGTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Novartis AG — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.02%). Which is the better fit depends on your goals.

AZNNVS
Market Cap
$250.84B$298.18B
Sector
HealthHealth
52-Week High
$209.48$168.62
52-Week Low
$147.06$119.31
Enterprise Value
$278.12B$339.50B
Dividend Yield
1.97%3.02%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS